Management of Hypertension in Pregnancy

Introduction to Hypertension Management

The American College of Cardiology recommends continuing labetalol 200 mg twice daily and monitoring blood pressure closely, with readiness to uptitrate to a maximum of 2400 mg daily if blood pressure remains elevated above 140/90 mmHg 1
Labetalol is well-established as safe and effective for gestational hypertension, with no association with teratogenicity and extensive clinical experience, according to the European Society of Cardiology 2

The European Society of Cardiology recommends a target blood pressure of 140-150/90-100 mmHg 3, 1, 4
Initiate or uptitrate antihypertensive therapy when BP is consistently ≥140/90 mmHg, as recommended by the American College of Cardiology 1
Avoid excessive lowering below 130/80 mmHg, as overly aggressive reduction can impair uteroplacental perfusion and compromise fetal development, according to the American College of Cardiology 1
The goal is to decrease mean arterial pressure by 15-25% when treating elevated pressures, as recommended by the American College of Cardiology 1, 4

If BP reaches ≥160/110 mmHg for >15 minutes, this constitutes a hypertensive emergency requiring immediate treatment within 30-60 minutes, according to the European Society of Cardiology 3, 4
First-line for severe hypertension: IV labetalol (starting 10-20 mg bolus, titrating 20-80 mg every 10-30 minutes, maximum 300 mg total), as recommended by the American College of Cardiology 1
Never use short-acting nifedipine with magnesium sulfate due to risk of precipitous hypotension, according to the American College of Cardiology 4

The American Heart Association recommends checking blood pressure at each visit, with home monitoring if available 5
Monitor symptoms of preeclampsia, such as severe headache, visual changes, right upper quadrant pain, and sudden edema, as recommended by the American College of Cardiology 4
Perform laboratory tests, including baseline and periodic monitoring of platelets, liver transaminases, creatinine, uric acid, and urine protein, according to the American College of Cardiology 6

Absolute contraindications for labetalol include second or third-degree AV block, as recommended by the American College of Cardiology 1, 4
Potential adverse effects to monitor include maternal bronchoconstriction, bradycardia, postural hypotension, and masking of hypoglycemia, according to the American College of Cardiology 1

The American Heart Association recommends nifedipine extended-release as a preferred alternative agent if labetalol is inadequate or contraindicated 7
Methyldopa is a traditional first-line agent with comparable efficacy to labetalol, though more side effects like drowsiness, according to the American College of Cardiology 1

The American College of Cardiology recommends avoiding ACE inhibitors, angiotensin receptor blockers (ARBs), direct renin inhibitors, and atenolol in pregnancy due to potential harmful effects on the fetus 1, 2, 4, 6

Recent evidence suggests labetalol may be less effective postpartum compared to calcium channel blockers and is associated with higher readmission rates, according to the American Heart Association 7
Plan to transition to once-daily agents (nifedipine, amlodipine, or enalapril) after delivery if continued treatment needed, as these are compatible with breastfeeding, as recommended by the American Heart Association 7